Zydus Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 2,947.30 | 4,266.80 | 3,693.50 |
| Operating Expense | 1,678.40 | 1,787.30 | 1,771.80 |
| Net Profit | 789.80 | 1,700.80 | 1,405.20 |
| Net Profit Margin | 26.80 | 39.86 | 38.05 |
| Earning Per Share | 7.85 | 16.90 | 13.89 |
| EBIDTA | 1,268 | 2,478.40 | 2,049.50 |
| Effective Tax Rate | 19.59 | 21.44 | 21.21 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 2947.30 |
| Operating Expense | 1678.40 |
| Net Profit | 789.80 |
| Net Profit Margin | 26.80 |
| Earning Per Share | 7.85 |
| EBIDTA | 1268.00 |
| Effective Tax Rate | 19.59 |
Invest in Zydus Lifesciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 10,818.70 | 8,731.60 | 7,836.90 |
| Operating Expenses Annual | 6,760 | 6,277.20 | 5,918.80 |
| Operating Profit Annual | 5,134.90 | 2,799 | 1,777.50 |
| Interest Annual | 390.70 | 278.20 | 134.90 |
| Depreciation | 504.40 | 488.60 | 478.70 |
| Net Profit Annual | 3,441.50 | 1,529.20 | 857.90 |
| Tax Annual | 798.30 | 503 | 306 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 10,818.70 |
| Operating Expenses Annual | 6,760 |
| Operating Profit Annual | 5,134.90 |
| Interest Annual | 390.70 |
| Depreciation | 504.40 |
| Net Profit Annual | 3,441.50 |
| Tax Annual | 798.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 240.40 | 294.50 | 154 |
| Cash Flow from Operations | 1,999.10 | 1,078.20 | 1,272.20 |
| Cash Flow from Investing | -1,830.60 | -1,959.30 | 586.20 |
| Cash Flow from Financing | -300.80 | 827 | -1,709.80 |
| Cash Flow at the End | 108.10 | 240.40 | 302.60 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 240.40 |
| Cash Flow from Operations | 1,999.10 |
| Cash Flow from Investing | -1,830.60 |
| Cash Flow from Financing | -300.80 |
| Cash Flow at the End | 108.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 47.46 | 32.06 | 26.80 |
| PBIT Margin (%) | 42.80 | 26.46 | 20.69 |
| PBT Margin (%) | 42.69 | 26.36 | 20.54 |
| Net PROFIT Margin (%) | 31.81 | 17.51 | 10.95 |
| Return On Networth / Equity (%) | 23.45 | 11.38 | 8.43 |
| Return On Networth /Employed (%) | 22.73 | 13.31 | 9.84 |
| Return On Assets (%) | 16.86 | 8.76 | 5.25 |
| Total Debt / Equity (X) | 0.37 | 0.28 | 0.25 |
| Asset Turnover Ratio (%) | 0.53 | 0.50 | 0.48 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 47.46 |
| PBIT Margin (%) | 42.80 |
| PBT Margin (%) | 42.69 |
| Net PROFIT Margin (%) | 31.81 |
| Return On Networth / Equity (%) | 23.45 |
| Return On Networth /Employed (%) | 22.73 |
| Return On Assets (%) | 16.86 |
| Total Debt / Equity (X) | 0.37 |
| Asset Turnover Ratio (%) | 0.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 4,376.60 | 4,184.10 | 4,335.90 |
| Total Current Assets Annual | 7,911.30 | 7,158.20 | 6,837.40 |
| Non Current Assets Annual | 16,149 | 13,405.40 | 10,902.60 |
| Total Shareholders Funds Annual | 15,716.50 | 13,639.40 | 13,240.50 |
| Total Assets Annual | 24,084.80 | 20,563.60 | 17,740 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 4,376.60 |
| Total Current Assets Annual | 7,911.30 |
| Non Current Assets Annual | 16,149 |
| Total Shareholders Funds Annual | 15,716.50 |
| Total Assets Annual | 24,084.80 |
EPS (INR)
Expected
9.06
Reported
9.06
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by -0.51%
